KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Treasury Shares: 2024

Historic Treasury Shares for Xenon Pharmaceuticals (XENE) over the last 1 years, with Dec 2024 value amounting to $210,000.

  • Xenon Pharmaceuticals' Treasury Shares rose 49.23% to $313,382 in Q3 2025 from the same period last year, while for Sep 2025 it was $313,382, marking a year-over-year increase of 49.23%. This contributed to the annual value of $210,000 for FY2024, which is N/A change from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Treasury Shares of $210,000 as of FY2024.
  • In the past 5 years, Xenon Pharmaceuticals' Treasury Shares ranged from a high of $210,000 in FY2024 and a low of $210,000 during FY2024.
  • Moreover, its 1-year median value for Treasury Shares was $210,000 (2024), whereas its average is $210,000.